Beta Drugs Ltd. September 17 Analyst Meet

Event Type: Group Meet organized by Valorem Advisors – Valorem CXO Meet
Date and Time: September 17, 2026 (Thursday) at 4:00 pm IST
Mode: Virtual meeting
Purpose: Management will discuss the company's growth journey and provide insights into the industry, operations, performance, vision, strategy, and address questions from the investor community
Management Participants: Mr. Rahul Batra, Chairman & Managing Director
Financial Period Discussion: While not explicitly stated as earnings-related, the meeting will cover financial highlights and future growth strategy
Presentation Availability: The document mentions an "investor kit link" available by clicking on the company logo, but no specific details about earnings deck or transcript availability are provided
UPSI Statement: The document does not contain any explicit statement regarding unpublished price sensitive information

The company has delivered a 5-year revenue CAGR of 27% and EBITDA CAGR of 25%
Targeting ~25% revenue CAGR through FY30
Company operates 3 WHO-GMP certified manufacturing facilities, with one additionally accredited by ANVISA, INVIMA and COFEPRIS
Has 180+ oncology-focused SKUs spanning chemotherapy, targeted and hormonal therapies
Products reach 85%+ of corporate and government hospitals in India
Presence across 46+ countries with 280+ dossier registrations and ~300 filed for registrations
API business provides backward integration, with 65%+ of APIs used for in-house formulations

The meeting will cover:

Pre-registration required to receive Zoom meeting invite
All participants' video and audio will be switched off
Participants can pre-request questions in registration form or ask during meeting via Zoom chat
The intimation was filed with NSE under Regulation 30 read with Schedule III (Part A) of SEBI LODR Regulations, 2015
Document reference: BDL/PKL/SEC/2026-27 dated 10th September, 2026
Signed by Rajni Brar, Company Secretary